Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • World Cup Coverage
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Medicare's new $50 weight-loss drug program

Digest more
Top News
Overview
Impacts
 · 1d
Medicare's new $50 weight-loss drug program: Who qualifies and what are the concerns?
Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65 and older or with disabilit...

Continue reading

 · 3d · on MSN
Here's what to know about Medicare's new GLP-1 weight-loss drug program
 · 2d · on MSN
Why Clinicians Worry Medicare’s New $50 Weight-Loss Program Could Backfire
 · 1d
Medicare’s new weight loss drug program just launched and older Americans are expected to flock to it
Millions more Americans will qualify for obesity medications at just $50 a month under a new Medicare program starting on Wednesday, bringing these highly effective drugs to people aged 65 and older a...

Continue reading

 · 1d
Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday
 · 1d
Pilot program to provide cheaper GLP-1 via Medicare stokes shortage fears
 · 1d
Beyond the GLP-1RA weight loss ceiling
Retatrutide's 30% weight loss marks it as the most competitive drug in development, says endocrinologist Dr. Sanjay Kalra from Bharti Hospital in Karnal, India, who predicts it will supplant Eli Lilly...

Continue reading

 · 1d
Nearly 4M Medicare beneficiaries could access GLP-1s for weight loss under new program: analysis
 · 1d
GLP-1 Access Program May Enable Affordable Access For Some On Medicare
World Cup Coverage
The latest news on World Cup
See more
  • Privacy
  • Terms